Search

everythinglearnresearchcommunity

for

Search:↓

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The man died from lung cancer, not the rare nail tumor.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

High-dose vitamin A was safe and well-tolerated in a lung cancer treatment study.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Certain cancer drugs can cause skin issues like rashes and itching.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.